| Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
|---|
| 06/08/2005 | EP1538138A1 Substituted benzanilide compound and pest control agent |
| 06/08/2005 | EP1392673B1 1,3-dihydroxybenzene derivatives and colorants containing said compounds |
| 06/08/2005 | CN1205213C Method for the production of imidazol-[1,2-c][2,3]-benzodiazepines and intermediates in production thereof |
| 06/08/2005 | CN1205181C Matrix metalloproteinase inhibitors |
| 06/08/2005 | CN1205179C (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
| 06/02/2005 | WO2005049604A2 Antithrombotic aromatic ethers |
| 06/02/2005 | WO2005049023A1 Glyt1 transporter inhibitors |
| 06/02/2005 | US20050119305 N-hydroxy-6-[(4-phenylbenzoyl)amino]hexanamide; hydroxamic acid derivative and equivalent thereof; antiinflammatory, anticarcinogenic, antiarthritic, antidiabetic agents; sepsis, leukemia, osteoporosis, skin disorders, cachexia, autoimmune diseases, hepatitis, endometriosis; hypergammaglobulinemia |
| 06/02/2005 | US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2005 | US20050119225 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 06/02/2005 | US20050118706 Polymer arrays |
| 06/01/2005 | EP1535920A1 Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives |
| 06/01/2005 | EP1535909A2 Cyclic amine derivatives and their use as drugs |
| 06/01/2005 | EP1534699A1 Kinetic resolution method |
| 06/01/2005 | EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 06/01/2005 | EP1534658A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/01/2005 | EP1534300A2 3, 10, and 12a substituted tetracycline compounds |
| 06/01/2005 | EP1534273A2 Modulators of the glucocorticoid receptor and method |
| 06/01/2005 | EP1534255A2 Processes for preparing 1,3-dioxolane nucleosides |
| 06/01/2005 | EP1351959B1 Novel pleuromutilin derivatives |
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 06/01/2005 | EP0994862B1 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 06/01/2005 | EP0993441B1 INHIBITORS OF p38 |
| 06/01/2005 | EP0946499B1 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/01/2005 | CN1204144C Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 06/01/2005 | CN1204135C 1, 3-dioxolanes with antitussive activity |
| 05/31/2005 | US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis |
| 05/31/2005 | US6900227 Benzodioxole derivatives |
| 05/26/2005 | WO2005046683A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/26/2005 | US20050113585 novel intermediates useful in the synthesis of 14 beta -hydroxy-1,14-carbonate-deacetylbaccatin III derivatives; 7,10-bistrichloroacetyl-10-deacetylbaccatin III; 13-dehydro-14 beta -hydroxy-7-triethylsilylbaccatin III; 13-dehydro-14 beta -hydroxy-7,10-bistrichloroacetyl-baccatin III 1,14-carbonate |
| 05/26/2005 | US20050113580 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 05/26/2005 | CA2541949A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/25/2005 | EP1532181A1 Fulvene, metallocene catalysts and preparation method thereof, and preparation of polyolefines copolymer using the same |
| 05/25/2005 | EP1532132A1 Novel benzodioxoles |
| 05/25/2005 | EP1532128A1 Inhibitors of hcv ns5b polymerase |
| 05/25/2005 | EP1532093A1 Hydroxylation process for aromatic compounds containing a dioxa- heterocyclic system |
| 05/25/2005 | EP1341742B1 Method for producing compounds having a cf2o bridge |
| 05/25/2005 | EP1185492B1 Acid-catalysed reactions |
| 05/25/2005 | EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/25/2005 | CN1620424A Compounds for the treatment of inflammatory disorders |
| 05/25/2005 | CN1620421A Substituted alkyl diamine |
| 05/25/2005 | CN1203080C Antitumor platinum (II) compound using camphor acid radical as ligand |
| 05/24/2005 | US6897343 From propylene oxide and carbon dioxide; using phosphorus catalyst; forming propylene carbonate as chemical intermediate |
| 05/24/2005 | US6897210 Anticancer agents; antiarthritic agents |
| 05/19/2005 | WO2005044790A1 Method for the catalytic hydrogenation of alkyne compounds |
| 05/19/2005 | WO2005044007A1 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient |
| 05/19/2005 | WO2005015158A9 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 05/19/2005 | WO2004092100A8 Indene derivatives as pharmaceutical agents |
| 05/19/2005 | US20050107469 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 05/19/2005 | US20050107448 Calcium receptor antagonists |
| 05/19/2005 | US20050107445 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis |
| 05/19/2005 | US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC |
| 05/19/2005 | DE10348044A1 Duale Alanyl-Aminopeptidase- und Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen Dual-alanyl aminopeptidase and dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases |
| 05/18/2005 | EP1530564A2 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 05/18/2005 | CN1617849A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 05/18/2005 | CN1616449A Asymmetric hexahydroxy biphenyl devicative and its preparing method |
| 05/18/2005 | CN1202063C Method for preparing phenol compound derivated from dialoxy acetaldehyde and use |
| 05/18/2005 | CN1202052C Enantioselective reduction of ketones with silane agent/metal compound/chiral ligand system |
| 05/17/2005 | US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus |
| 05/17/2005 | US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine |
| 05/12/2005 | WO2005042512A1 Process for synthesising heliotropine and its derivatives |
| 05/12/2005 | WO2005042511A1 Novel fluorine compound and fluoropolymer |
| 05/12/2005 | WO2005041684A2 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 05/12/2005 | WO2004072087A3 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
| 05/12/2005 | WO2004048318A8 Improved process for the preparation of 1,3-substituted indenes |
| 05/12/2005 | US20050101787 Reaction of metal complex and nitrogen compound to form nitro or nitrile complex |
| 05/12/2005 | US20050101671 Compounds and compositions for delivering active agents |
| 05/12/2005 | CA2535036A1 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 05/11/2005 | EP1529040A1 Endiandric acid h derivatives as c-maf inhibitors for using against asthma |
| 05/11/2005 | EP0951464B1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 05/11/2005 | CN1200940C Triazole pyrimidine compounds |
| 05/11/2005 | CN1200924C Preparation of cyclohexene carboxylic acid derivative |
| 05/11/2005 | CN1200699C Anthracyclinone derivatives and their use in amyloidosis |
| 05/10/2005 | US6890955 Drugs for treating obesity and diabetes and animal feed additives |
| 05/10/2005 | US6890949 Amino ceramide-like compounds and therapeutic methods of use |
| 05/06/2005 | WO2005040149A1 Process for the preparation of glyceraldehyde acetonide |
| 05/06/2005 | WO2005040148A1 New rar$g(b) receptor-activating ligand, method for the preparation thereof and use thereof in human medicine and in cosmetics |
| 05/06/2005 | WO2005040109A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 05/06/2005 | WO2005040100A1 Tetrahydro-naphthalene and urea derivatives |
| 05/06/2005 | WO2005027157A3 Salt fusible at ordinary temperature and electrochemical device |
| 05/06/2005 | WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 05/06/2005 | CA2543303A1 Process for the preparation of glyceraldehyde acetonide |
| 05/06/2005 | CA2542494A1 Tetrahydro-naphthalene and urea derivatives |
| 05/06/2005 | CA2539193A1 New rarbeta receptor-activating ligand, method for the preparation ther eof and use thereof in human medicine and in cosmetics |
| 05/05/2005 | US20050096473 Reacting 1,1'-thiocarbonyldiimidazole with an aryl amine, e.g., benzylamine, to form 1830 thiourea (or urea)prodoucts; high speed, automatic process; anticarcinogenic agents, leukemia; enzyme inhibitors for HIV reverse transcriptase (polymerase) |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/05/2005 | US20050095652 Solid support comprising immobilized biopolymers for use as assay in monitoring receptor ligand interaction; drug screening; antibodiy sensitivity |
| 05/04/2005 | EP1527064A2 Preparation of lactic acid derivatives and their use |
| 05/04/2005 | EP1527063A1 The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
| 05/04/2005 | EP1042841A4 Non-aqueous electrolyte for electrochemical systems and lithium secondary battery comprising the same |
| 05/04/2005 | EP0946537B1 Process for the stereoselective production of nitro-enamine compounds |
| 05/04/2005 | CN1612852A Lipoxin A4 analogs |
| 05/04/2005 | CN1199957C 'Sqiqu site' derivative and its preparing method as well as its activity of anti asthma |
| 05/03/2005 | US6888027 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 05/03/2005 | US6888012 Reducing an alpha -haloketone compound by asymmetric hydrogen transfer in presence of a group 9 transition metal compound having a substituted or unsubstituted cyclopentadienyl group and an optically active diamine compound |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 05/03/2005 | US6887863 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors |